These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16728512)

  • 21. Acceptability of traditional healers as directly observed treatment providers in tuberculosis control in a tribal area of Andhra Pradesh, India.
    Banerjee A; Sharma BV; Ray A; Kannuri NK; Venkateswarlu TV
    Int J Tuberc Lung Dis; 2004 Oct; 8(10):1260-5. PubMed ID: 15527160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple perspectives on diagnosis delay for tuberculosis from key stakeholders in poor rural China: case study in four provinces.
    Yan F; Thomson R; Tang S; Squire SB; Wang W; Liu X; Gong Y; Zhao F; Tolhurst R
    Health Policy; 2007 Jul; 82(2):186-99. PubMed ID: 17055105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study.
    Wei X; Liang X; Liu F; Walley JD; Dong B
    Int J Tuberc Lung Dis; 2008 May; 12(5):538-47. PubMed ID: 18419890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family physicians managing tuberculosis. Qualitative study of overcoming barriers.
    Jackson L; Yuan L
    Can Fam Physician; 1997 Apr; 43():649-55. PubMed ID: 9111981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective.
    Tang S; Squire SB
    Health Policy; 2005 Apr; 72(1):93-104. PubMed ID: 15760702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Listening to those on the frontline: lessons for community-based tuberculosis programmes from a qualitative study in Swaziland.
    Escott S; Walley J
    Soc Sci Med; 2005 Oct; 61(8):1701-10. PubMed ID: 15967558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
    Keshavjee S; Gelmanova IY; Pasechnikov AD; Mishustin SP; Andreev YG; Yedilbayev A; Furin JJ; Mukherjee JS; Rich ML; Nardell EA; Farmer PE; Kim JY; Shin SS
    Ann N Y Acad Sci; 2008; 1136():1-11. PubMed ID: 17954675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinic staff perceptions of tuberculosis treatment delivery in Bali.
    Watkins RE; Plant AJ
    Patient Educ Couns; 2005 Mar; 56(3):340-8. PubMed ID: 15721977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing WHO DOTS strategy in the Russian Federation: stakeholder attitudes.
    Atun RA; Baeza J; Drobniewski F; Levicheva V; Coker RJ
    Health Policy; 2005 Oct; 74(2):122-32. PubMed ID: 16153473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shifting the paradigm in tuberculosis control: illustrations from India.
    Ogden J; Rangan S; Uplekar M; Porter J; Brugha R; Zwi A; Nyheim D
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):855-61. PubMed ID: 10524581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users.
    Neale J; Tompkins C; Sheard L
    Health Soc Care Community; 2008 Mar; 16(2):147-54. PubMed ID: 18290980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outcomes and problems of DOTS strategy in Japan].
    Ahiko T
    Kekkaku; 2007 Feb; 82(2):119-23. PubMed ID: 17373322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Government-NGO collaboration: the case of tuberculosis control in Bangladesh.
    Zafar Ullah AN; Newell JN; Ahmed JU; Hyder MK; Islam A
    Health Policy Plan; 2006 Mar; 21(2):143-55. PubMed ID: 16434423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges in providing drug user treatment services in Russia: providers' views.
    Bobrova N; Rughnikov U; Neifeld E; Rhodes T; Alcorn R; Kirichenko S; Power R
    Subst Use Misuse; 2008; 43(12-13):1770-84. PubMed ID: 19016164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient empowerment in tuberculosis control: reflecting on past documented experiences.
    Macq J; Torfoss T; Getahun H
    Trop Med Int Health; 2007 Jul; 12(7):873-85. PubMed ID: 17596255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community involvement in tuberculosis control: lessons from other health care programmes.
    Hadley M; Maher D
    Int J Tuberc Lung Dis; 2000 May; 4(5):401-8. PubMed ID: 10815732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to care seeking in directly observed therapy short-course (DOTS) clinics and tuberculosis control in southern Nigeria: a qualitative analysis.
    Okeibunor JC; Onyeneho NG; Chukwu JN; Post E
    Int Q Community Health Educ; 2006-2007; 27(1):23-37. PubMed ID: 18039627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm?
    Lienhardt C; Ogden JA
    Trop Med Int Health; 2004 Jul; 9(7):833-41. PubMed ID: 15228495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Reasonable access' to primary care: assessing the role of individual and system characteristics.
    Wellstood K; Wilson K; Eyles J
    Health Place; 2006 Jun; 12(2):121-30. PubMed ID: 16338628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.